ReviewDermatology and therapy2025
Bioactives for Estrogen-Deficient Skin: Topical and Oral Supplement Clinical Studies. A Narrative Review.
Review in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels -A Narrative Review.Dermatology and therapy · 2026Review
- Overview of Aging, Skin Health, Estrogen, Menopause and HRT.Life (Basel, Switzerland) · 2026Article
- Assessing the Roles of Aging, Estrogen, Nutrition, and Neuroinflammation in Women and Their Involvement in Alzheimer's Disease-A Narrative Overview.International journal of molecular sciences · 2026Review
- Round Table Discussion: Aesthetic Treatment Considerations for the Perimenopausal & Menopausal Patient.Journal of cosmetic dermatology · 2026Review
- A 6-Month, Prospective, Multi-arm Study for the Efficacy of Standardized Nutraceuticals to Improve Hair Fiber Thickness and Strength.Dermatology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Bioactive compound applications by topical or oral administration have gained increased utilization/awareness in providing health benefits particularly due to changes in hormone levels and aging, especially in women with the decline and loss of estrogens. This narrative review focuses on the bioactive compounds such as the phytoestrogens that have estrogenic properties for improving skin health. Notably, phytoestrogens bind and/or activate estrogen beta receptors, which are abundant in skin layers to improve dermal health. This review presents: (a) skin characteristics with aging in women, (b) changes in hormone levels with aging in women (especially with estrogen deficiency), (c) the characteristics of phytoestrogens and other bioactive compounds, (d) topical and oral clinical studies of bioactive compounds (phytoestrogens) as antiaging treatment(s) for estrogen-deficient skin (during peri- and postmenopause), and (e) the advantages of treating the skin from the outside to inside by traditional topical therapies and treating the skin from the inside to the outside by nutraceutical supplementation, which represents a relatively new innovation of increasing popularity. While this is a growing area of research with promising results, more investigations are needed to understand the mechanism(s) of how combination ingredient formulations work to improve skin health and slow down the advancement of the aging process.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.